Mannkind (MNKD) Current Leases (2021 - 2024)
Mannkind's (MNKD) quarterly Current Leases came in at $9.9 million in Q1 2024, up 2.85% year-on-year from $9.6 million in Q2 2023, and up 1.02% on a QoQ basis from $9.8 million in Q4 2023.
Mannkind (MNKD) Current Leases (2021 - 2024) Analysis & Trends
Mannkind (MNKD) has 4 years of Current Leases data on file, last reported at $9.9 million in Q1 2024.
- On a quarterly basis, Current Leases rose 2.85% year-over-year to $9.9 million in Q1 2024; TTM through Mar 2024 was $9.9 million, a 2.85% increase from a year earlier, with the FY2023 full-year figure at $9.8 million, up 2.46% from the prior year.
- Current Leases for Q1 2024 stood at $9.9 million, up from $9.8 million in the prior quarter.
- Over the last five years, Current Leases for MNKD reached as high as $9.9 million in Q1 2024 and fell as low as $7.0 million in Q4 2021.
- Historically, Current Leases has averaged $9.4 million across 4 years, with a median of $9.6 million in 2022.
- Across the five-year window, Current Leases surged 36.64% in 2022 and grew 2.11% in 2023, its largest moves.
- Year by year, Current Leases stood at $7.0 million in 2021, then surged by 36.64% to $9.6 million in 2022, then climbed by 2.46% to $9.8 million in 2023, then gained by 1.02% to $9.9 million in 2024.
- Per Business Quant data, the three most recent Current Leases figures were $9.9 million in Q1 2024, $9.8 million in Q4 2023, and $9.7 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 9.90 Mn |
| Dec 31, 2023 | 9.80 Mn |
| Sep 30, 2023 | 9.75 Mn |
| Jun 30, 2023 | 9.70 Mn |
| Mar 31, 2023 | 9.63 Mn |
| Dec 31, 2022 | 9.57 Mn |
| Sep 30, 2022 | 9.53 Mn |
| Jun 30, 2022 | 9.50 Mn |
| Mar 31, 2022 | 9.41 Mn |
| Dec 31, 2021 | 7.00 Mn |